Feel free to get in touch for information about selling your healthcare business in The Netherlands. Our M&A advisors know the healthcare industry in the Netherlands very well. Our people have many years of experience in the Dutch healthcare industry. We help you to sell your healthcare company in the Netherlands to international buyers. Our M&A advisors are ready to assist you with selling your healthcare business. Corporate Finance in Europe’s team provides M&A services through deep understanding of the value chain of the healthcare industry. When selling your Dutch healthcare business knowing the market and leading international buyers is crucial. We guide you in the full process of selling your healthcare company. Please get in touch with us to learn more about selling a healthcare company in the Netherlands.
Let us inform you about the sale of a Dutch company
Download the Corporate Finance in Europe M&A presentation to find out how we can help you with the sale of your healthcare company in the Netherlands.
It is necessary to know the best practices in the process of selling a business. We think this is of high importance and want to help you in the process of selling your company. This starts with the preparation. Being an European M&A network we know the legal and tax aspects concerning the sale. On top of our healthcare industry focus we offer further services during the process of the sale of your business. Examples of these services include valuations, due diligence, legal or tax M&A support. Read more on the various aspects when selling a business at the page sell your business in Europe.
The healthcare landscape is very diverse in the Netherlands. Many different type of healthcare companies can be found. Our M&A advisors in the Netherlands know the Dutch healthcare market in and out. There is a lot of interesting healthcare companies to sell in the Netherlands. Our Dutch healthcare M&A advisors can help you to sell healthcare companies of the following type of firms:
The healthcare market in the Netherlands is of a large size. The medicine usage in the Netherlands is fairly low as medicines are not quickly prescribed. The percentage of the cost of medicines within the total healthcare expenditure in the Netherlands is around 10%. This is considerably lower than in most other European countries.The healthcare market is still developing further in the Netherlands. The regulations do not differ too much from other countries and research of clinical trials can only start after authorization has been obtained. Authorization is required from the medical ethics committees of the participating hospitals. The Dutch Law for medical research involving humans (Wmo) states that clinical trial applications need to be processed within 90 days. This is one and a half times longer than the requirement stipulated by the EU directive. As in other countries clinical trials are an important part of the development of a new medicine.
Feel free to get in touch for information about selling a healthcare business in the Netherlands. Our M&A advisors know the healthcare industry in the Netherlands well. We speak the local Dutch language. The advisors of CFIE help you to sell your healthcare company in the Netherlands. Please get in touch with us to learn more about selling a healthcare company in the Netherlands.